Effects of in vivo sodium azide administration on the immunohistochemical localization of kynurenine aminotransferase in the rat brain

Neuroscience

Volumn 94, Issue 1, 1999, Pages 269-277

  Knyihar Csillik E ^a   Okuno, E ^b   Vecsei L ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Brain; Excitotoxins; Immunocytochemistry; Kynurenine aminotransferase I; Rat; Sodium azide

Indexed keywords

CYTOCHROME C OXIDASE; CYTOCHROME C OXIDASE INHIBITOR; EXCITATORY AMINO ACID RECEPTOR; EXCITOTOXIN; KYNURENINE AMINOTRANSFERASE; SODIUM AZIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN HYPOXIA; CELL ULTRASTRUCTURE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENZYME LOCALIZATION; FEMALE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NERVE DEGENERATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT;

ANIMALS; BRAIN; BRAIN CHEMISTRY; CELL COUNT; CORPUS STRIATUM; ENZYME INHIBITORS; FEMALE; HIPPOCAMPUS; LYASES; MALE; MICROSCOPY, ELECTRON; NEUROGLIA; NEURONS; NEUROTOXINS; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; SODIUM AZIDE; TEMPORAL LOBE; TRANSAMINASES;

EID: 0032871187     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(99)00306-1     Document Type: Article

References (50)

1. Albin R.L., Greenamyre J.T. Alternative excitotoxic hypothesis. Neurology. 42:1992;733-738.
2. Beal M.F. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann. Neurol. 31:1992;119-130.
3. Beal M.F., Swartz K.J., Hyman B.T., Storey E., Finn S.F., Koroshetz W. Aminooxyacetic acid results in excitotoxin lesions by a novel indirect mechanism. J. Neurochem. 57:1991;1068-1073.
4. Brouillet E., Hyman B.T., Jenkins B.G., Henshaw D.R., Schulz J.B., Sodhi P., Rosen B.R., Beal M.F. Systemic or local administration of azide produces striatal lesions by an energy impairment-induced excitotoxic mechanism. Expl Neurol. 129:1994;175-182.
5. Buchli R., Alberati-Giani D., Malherbe P., Köhler C., Broger C., Cesura A.M. Cloning and functional expression of a soluble form of kynurenine/α-aminoadipate aminotransferase from rat kidney. J. biol. Chem. 270:1995;29,330-29,335.
6. Cajal, S. Ramon y (1995) Histology of the Nervous System (translated from the Spanish by Azoulay L., and from the French by Swanson N. and Swanson L. W.), Vol. II, p. 611. Oxford University Press, New York.
7. Carpenter M. B. and Sutin J. (1983) Human Neuroanatomy, 8th edn. Williams & Wilkins, Baltimore.
8. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1:1988;623-634.
9. Choi D.W., Rotman S.M. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. A. Rev. Neurosci. 13:1990;171-182.
10. Du F., Schmidt W., Okuno E., Kido R., Köhler C., Schwarcz R. Localization of kynurenine aminotransferase immunoreactivity in the rat hippocampus. J. comp. Neurol. 321:1992;477-487.
11. Du F., Williamson J., Bertram E., Lothman E., Okuno E., Schwarcz R. Kynurenine pathway enzymes in a rat model of chronic epilepsy: immunohistochemical study of activated glial cells. Neuroscience. 55:1993;975-989.
12. 3H]NMDA as ligands for NMDA receptors in crude post-synaptic densities from rat brain. Eur. J. Pharmac. 133:1987;291-300.
13. Golgi C. (1886) Sulla fina anatomia degli organi centrali del sistema nervoso. Edizione d'autore, Milano.
14. Guidetti P., Okuno E., Schwarcz R. Characterization of rat brain kynurenine aminotransferases I and II. J. Neurosci. Res. 50:1997;457-465.
15. Hicks S.P. Brain metabolism in vivo. II. Archs Path. 50:1950;545-561.
16. Hodgkins P.S., Schwarcz R. Interference with cellular energy metabolism reduces kynurenic acid formation in rat brain slices: reversal by lactate and pyruvate. Eur. J. Neurosci. 10:1998;1986-1994.
17. Hurst E.W. Experimental demyelination of the central nervous system. 3. Poisoning with potassium cyanide, sodium azide, hydroxylamine, narcotics, carbon monoxide, etc., with some consideration of bilateral necrosis occurring in the basal nuclei. Aust. J. exp. Biol. med. Sci. 20:1942;297-312.
18. Jauch D., Urbanska E.W., Guidetti P., Birch E.D., Vonsattel J.P.G., Whetsell W.O., Schwarcz R. Dysfunction of brain kynurenic acid metabolism in Huntington's disease: focus on kynurenine aminotransferases. J. neurol. Sci. 130:1995;39-47.
19. Kapoor R., Okuno E., Kido R., Kapoor V. Immuno-localization of kynurenine aminotransferase (KAT) in the rat medulla and spinal cord. NeuroReport. 16:1997;3619-3623.
20. Kessler M., Terramani T., Lynch G., Baudry M. A glycine site associated with N-methyl-D-aspartic acid receptors: characterization and identification of a new class of antagonists. J. Neurochem. 52:1989;1319-1328.
21. Kleckner N.W., Dingledine R. Requirement for glycine in activation of NMDA receptors expressed in Xenopus oocytes. Science. 241:1988;835-836.
22. Lorente de Nó R. Studies on the structure of the cerebral cortex. II. Continuation of the study of the ammonic system. J. Psychol. Neurol. 46:1934;113-177.
23. Malherbe P., Alberati-Giani D., Köhler C., Cesura A.M. Identification of a mitochondrial form of kynurenine aminotransferase/glutamine transaminase K from rat brain. Fedn Eur. biochem. Socs Lett. 367:1995;141-144.
24. McLean I.W., Nakane P.K. Periodate-lysine-paraformaldehyde fixative. A new fixative for immunoelectron microscopy. J. Histochem. Cytochem. 22:1974;1077-1083.
25. McMaster O.G., Du F., French E.D., Schwarcz R. Focal injection of aminooxyacetic acid produces seizures and lesions in rat hippocampus: evidence for mediation by NMDA receptors. Expl Neurol. 113:1991;367-374.
26. McMaster O.G., Baran H., Wu H.-Q., Du F., French E.D., Schwarcz R. Gamma-acetylenic GABA produces axon-sparing neurodegeneration after focal injection into the rat hippocampus. Expl Neurol. 124:1993;184-191.
27. Meldrum B., Garthwaite J. Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends pharmac. Sci. 11:1990;379-387.
28. Mettler F.A. Choreoathetosis and striopallidal necrosis due Mettler to sodium azide. Expl Neurol. 34:1972;291-308.
29. Miyoshi K. Experimental striatal necrosis induced by sodium azide. Acta neuropath., Berlin. 9:1967;199-216.
30. Monaghan D.T., Holets V.R., Toy D.W., Cotman C.W. Anatomical distributions of four pharmacologically distinct H-L-glutamate binding sites. Nature. 306:1983;176-179.
31. Novelli A., Reilly J.A., Lysko P.G., Henneberry R.C. Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res. 451:1988;205-212.
32. Nozaki K., Beal M.F. Neuroprotective effect of L-kynurenine on hypoxia-ischemia and NMDA lesions in neonatal rats. J. cerebr. Blood Flow Metab. 12:1992;400-407.
33. Okuno E., Du F., Ishikawa M., Tsujimoto M., Nakamura M., Schwarcz R., Kido R. Purification and characterization of kynurenine-pyruvate aminotransferase from rat kidney and brain. Brain Res. 354:1990;37-44.
34. Okuno E., Nakamura M., Schwarcz R. Two kynurenine aminotransferases in human brain. Brain Res. 542:1991;307-312.
35. Ottersen O. P. and Storm-Mathisen M. (1989) Excitatory and inhibitory amino acids in the hippocampus. In The Hippocampus: New Vistas (eds Chan-Palay V. and Kohler C.), pp. 97-117. Alan R. Liss, New York.
36. Palacios-Pru E., Miranda-Contreras L., Mendoza R.V., Zambrano E. Dendritic RNA and postsynaptic density formation in chick cerebellar synaptogenesis. Neuroscience. 24:1988;111-118.
37. Perkins M.N., Stone T.W. An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid. Brain Res. 247:1982;184-187.
38. Roberts R.C., Du F., McCarthy K., Okuno E., Schwarcz R. Immunocytochemical localization of kynurenine aminotransferase in the rat striatum: a light and electron microscopic study. J. comp. Neurol. 326:1992;82-90.
39. Schwarcz R. Jr, Foster A.C., French E.D., Whetsell W.O., Köhler C. Excitotoxic models for neurodegenerative diseases. Life Sci. 35:1984;19-32.
40. Schwarcz R., Du F., Schmidt W., Turski W. A., Gramsbergen J. B. P., Okuno E. and Roberts R. C. (1992) Kynurenic acid: a potential pathogen in brain disorders. In Neurotoxins and Neurodegenerative Disease (eds Langston J. W. and Young A.), Annals of the New York Academy of Sciences, Vol. 648, pp. 140-153. New York Academy of Sciences, New York.
41. Siesjö B. K. (1991) The role of calcium in cell death. In Neurodegenerative Disorders: Mechanisms and Prospects for Therapy (eds Price D. L., Thoenen H. and Aguayo A. J.), pp. 35-59. Wiley, Chichester.
42. Stevens J.L., Ayoubi N., Robbins J.D. The role of mitochondrial matrix enzymes in the metabolism and toxicity of cysteine conjugates. J. biol. Chem. 263:1988;3395-3401.
43. Stone T.W. Neuropharmacology of quinolinic and kynurenic acids. Pharmac. Rev. 45:1993;309-379.
44. Stone T. W., Burton N. R. and Smith D. A. S. (1989) Electrophysiology of quinolinic acid and other kynurenines, and their potential roles in the CNS. In Quinolinic Acid and the Kynurenines (ed. Stone T. W.), pp. 14-148. CRC, Boca Raton, FL.
45. Urbanska E., Ikonomidou C., Sieklucka M., Turski W.A. Aminooxyacetic acid produces excitotoxic lesions in rat striatum. Synapse. 9:1991;129-135.
46. Vécsei L., Beal M.F. Behavioral and pharmacological effects of centrally administered aminooxyacetic acid in rats. Eur. J. Pharmac. 220:1992;259-262.
47. Wu H.-Q., Salituro F.G., Schwarcz R. Enzyme-catalyzed production of the neuroprotective NMDA receptor antagonist 7-chlorokynurenic acid in the rat brain in vivo. Eur. J. Pharmac. 319:1997;13-20.
48. Zeevalk G.D., Nicklas W.J. Chemically induced hypoglycemia and anoxia: relationship to glutamate receptor-mediated toxicity in retina. J. Pharmac. exp. Ther. 253:1990;1285-1292.
49. Zeevalk G.D., Nicklas W.J. Mechanisms underlying initiation of excitotoxicity associated with metabolic inhibition. J. Pharmac. exp. Ther. 257:1991;870-878.
50. 2+ block at the N-methyl-D-aspartate receptor underlies receptor activation during inhibition of neuronal metabolism. J. Pharmac. exp. Ther. 259:1992;1211-1220.